Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

 

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
S

SOHO 2021 Update on CLL: Molecular and Microenvironmental Basis of Immunodysfunction

By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Silvia Deaglio
By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Silvia Deaglio
1 view
September 30, 2021
0 Comments
Login to view comments. Click here to Login
Leukemia
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in ALL

Feat. B. Shah
09:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in AML

Feat. H. Kantarjian
10:37
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in CLL

Feat. S. O'Brien
11:49
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in CML

Feat. J. Cortés
16:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Managing TKI Resistance in CML: New Options

Feat. D. Rea
16:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update: State-of-the-Art in CML

Feat. A. Hochhaus
16:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on CML and Pregnancy

Feat. E. Abruzzese
11:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 OPTIC Primary Analysis on CP-CML: A Dose-Optimization Stud…

Feat. J. Cortés
14:51
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Treatment-Free Remission in CML

Feat. E. Atallah
21:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: Managing Cytopenias on TKI Therapy in CML

Feat. J. Apperley
18:11
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Use of MRD in CLL: American Perspective

Feat. M. Davids
24:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Use of MRD in CLL: European Perspective

Feat. O. Al-Sawaf
17:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on CLL: Molecular and Microenvironmental Basis of I…

Feat. S. Deaglio
15:56
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Management of Infections in Patients With CLL

Feat. C. Niemann
11:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate: Do Old Prognostic Markers Still Have a Role in CLL…

Feat. I. Ahn
10:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on Old Prognostic Markers in CLL Management: Do The…

Feat. S. Coutre
18:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Approaches to Therapy of Richter's Syndrome in CLL

Feat. D. Rossi
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: New Targetable Pathways in CLL

Feat. A. Danilov
08:20
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 BRUIN Trial Update on Previously Treated CLL/SLL: Pirtobru…

Feat. C. Coombs
20:46
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Management of Advanced CML: Blast Crisis

Feat. M. Deininger
11:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: How Can We Improve on AML MRD Assessment by Flow Cytometry

Feat. S. Freeman
12:54
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Menin Inhibitors in AML: What Are the Prospects?

Feat. E. Wang
09:10
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Novel Strategies to Treat Elderly With AML

Feat. T. Kadia
13:23
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Conventional Chemotherapy-Free Regimens in ALL

Feat. M. Wieduwilt
09:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Approach to Ph+ ALL: From Worst to Best?

Feat. P. Kebriaei
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Chemoresistance and Drug Profiling in ALL

Feat. B. Bornhauser
16:00
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on the Resistance to BCL-2i in CLL

Feat. C. Tam
11:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on the Resistance to BTKi in CLL

Feat. J. Woyach
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Cellular Therapy for CLL

Feat. T. Kipps
13:01
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Genomically Guided Frontline Therapy in CML

Feat. T. Hughes
14:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Molecular Testing of CML Patients: Between Old a…

Feat. S. Soverini
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on the Approach to the Elderly Patients With AL…

Feat. S. Chiaretti
16:02
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Novel Transplant and Post-transplant Options in …

Feat. A. Logan
10:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on the Use of BCL2i in ALL: Targeting Apoptosis

Feat. W. Stock
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Familial Predisposition to AML: How Far Are We i…

Feat. L. Godley
16:28
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Beyond BCL2 Inhibition & Prospects for MCL1 Inhibitor…

Feat. M. Konopleva
11:43
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights on Single Cell Profiling in AML

Feat. K. Takahashi
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: 1L Treatment in an Older Patient With TN-CLL W…

Feat. N. Lamanna
05:15
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Study: Relapse After 1L BTKi Therapy in RR-CLL Patien…

Feat. N. Lamanna
07:42
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: CLL Refractory to BTKi and to Venetoclax

Feat. J. Burke
06:17
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Richter's Transformation of CLL to DLBCL

Feat. J. Burke
06:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Feat. D. Stephens
05:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Feat. D. Stephens
12:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Response and Progression in CML

Feat. J. Radich
14:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on the Importance of BCR-ABL Transcript Type in CML

Feat. N. Cross
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on New Drugs and New Challenges in CML

Feat. J. Cortés
14:55
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Hyper-CVAD in ALL: Lessons Learned and New Appr…

Feat. E. Jabbour
17:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on MRD in ALL: Techniques and Therapeutic Utility O…

Feat. L. Muffly
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Data on Novel CAR-T Constructs for ALL

Feat. P. Lu
15:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Asparaginase in Adults With ALL: Understanding …

Feat. I. Aldoss
15:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Highlights: Novel Approaches to T-Cell ALL

Feat. D. Teachey
14:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Optimal Time for Blinatumomab in ALL: Is It …

Feat. R. Rau
12:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Optimal Time for CAR-T in Pediatric B-ALL: I…

Feat. R. Gardner
11:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Childhood ALL: The Impact of Genetic Ancestry on…

Feat. S. Lee
15:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on IDH-Mutated AML: Beyond Enasidenib and Ivosideni…

Feat. C. DiNardo
15:44
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on FLT3-Mutated AML: Moving Towards Cure

Feat. A. Perl
12:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Antibody-Based Therapy in AML: Immunotoxins and …

Feat. A. Fathi
15:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 New Horizons in TP53-Mutated AML

Feat. N. Daver
14:05
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Debate on the Maintenance Therapy in AML: Is It Necessary?

Feat. F. Ravandi
16:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Debate: Is Maintenance Therapy in AML Necessary?

Feat. J. Lancet
15:41
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on MRD in AML

Feat. J. Cloos
10:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Update on Newly Diagnosed AML: Venetoclax Combined With FL…

Feat. C. Lachowiez
08:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on Algorithmic Diagnostic Approach and Spectrum of …

Feat. A. Ferrer
17:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Managing CLL Patients Relapsed or Refractory to…

Feat. J. Brown